Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA

CASE DETAILS:  According to the Complaint, Intellia made false and misleading statements to the market when it allegedly gave investors the false impression that it had reliable information about the development and marketing of NTLA-3001. The Company's reports on timelines including future studies of its drug were not sustainable or viable due to expensive and inefficient delivery methods. The Company was not capable of providing patients with timely doses of NTLA-3001 or even to maintain full staffing

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

 Eastchester, NY 10709

Phone: 914-206-9742

Email: David@djslawllp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights--ntla-302427234.html

SOURCE DJS Law Group LLP